Back to search
FDAFDA · Food and drugs·Recall number D-0283-2022

Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409

Published December 22, 2021 · Recall initiated: December 3, 2021

Summary

FDA records drug Class II recall D-0283-2022, published December 22, 2021 and initiated December 3, 2021. Recalling firm: Valgene Incorporated dba Cape Drugs; Status: Terminated; Reported quantity: 27 vials; Lot: Lot #: 188008, BUD 03/19/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valgene Incorporated dba Cape Drugs
Distributor
Maryland Only
Lot
Lot #: 188008, BUD 03/19/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409 recalled?

Yes. FDA published recall D-0283-2022 on December 22, 2021. Reported hazard: Lack of Processing Controls

What should I do if I have this product?

Voluntary: Firm initiated · Telephone